Search Results - "Spoelstra, Femke O B"

Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors by Finazzi, Tobias, Palacios, Miguel A., Spoelstra, Femke O.B., Haasbeek, Cornelis J.A., Bruynzeel, Anna M.E., Slotman, Ben J., Lagerwaard, Frank J., Senan, Suresh

“…As patients with centrally located lung tumors are at increased risk of toxicity with stereotactic ablative radiation therapy (SABR), we performed stereotactic…”
Get full text

A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results by Bruynzeel, Anna M.E., Tetar, Shyama U., Oei, Swie S., Senan, Suresh, Haasbeek, Cornelis J.A., Spoelstra, Femke O.B., Piet, Anna H.M., Meijnen, Philip, Bakker van der Jagt, Marjolein A.B., Fraikin, Tamara, Slotman, Berend J., van Moorselaar, Reindert J.A., Lagerwaard, Frank J.

“…Use of stereotactic body radiation therapy (SBRT) is increasing in patients with localized prostate cancer, but concerns about early and late gastrointestinal…”
Get full text

Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors by Finazzi, Tobias, Palacios, Miguel A., Haasbeek, Cornelis J.A., Admiraal, Marjan A., Spoelstra, Femke O.B., Bruynzeel, Anna M.E., Slotman, Berend J., Lagerwaard, Frank J., Senan, Suresh

“…•Twenty-five peripheral lung tumors were treated using stereotactic MR-guided adaptive radiation therapy (SMART).•Gated breath-hold delivery resulted in PTVs…”
Get full text

Role of Adaptive Radiotherapy During Concomitant Chemoradiotherapy for Lung Cancer: Analysis of Data From a Prospective Clinical Trial by Spoelstra, Femke O.B., M.D, Pantarotto, Jason R., M.D., F.R.C.P.C, van Sörnsen de Koste, John R., Ph.D, Slotman, Ben J., M.D., Ph.D, Senan, Suresh, M.R.C.P., F.R.C.R., Ph.D

“…Purpose Respiratory-gated radiotherapy allows for the reduction of the toxicity associated with concomitant chemoradiotherapy, but the smaller fields used…”
Get full text

High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer by Huang, Kitty, Senthi, Sashendra, Palma, David A, Spoelstra, Femke O.B, Warner, Andrew, Slotman, Ben J, Senan, Suresh

“…Abstract Background and purpose Early detection of local recurrences following stereotactic ablative radiotherapy (SABR) for lung cancer may allow for curative…”
Get full text

Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease by Finazzi, Tobias, Ronden-Kianoush, Merle I, Spoelstra, Femke O B, Nossent, Esther J, Nijman, Suzan F M, Bahce, Idris, Dickhoff, Chris, Senan, Suresh

Get more information

Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer by Ronden, Merle I., Bahce, Idris, Hashemi, Sayed M.S., Dickhoff, Chris, de Haan, Patricia F., Becker, Annemarie, Spoelstra, Femke O.B., Dahele, Max R., Ali, Rania, Tiemessen, Marian A., Tarasevych, Svitlana, Maassen van den Brink, Karen, Haasbeek, Cornelis J.A., Daniels, Johannes M.A., van Laren, Marjolein, Verbakel, Wilko F.A.R., Senan, Suresh

“…•MDT decision-making for stage III NSCLC was studied between 2015–2017.•Surgery or chemo-radiotherapy were recommended in just 61 % of patients.•Deaths from…”
Get full text

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy by Finazzi, Tobias, van Sörnsen de Koste, John R., Palacios, Miguel A., Spoelstra, Femke O.B., Slotman, Berend J., Haasbeek, Cornelis J.A., Senan, Suresh

“…•MR-guidance enables high precision single-fraction lung SABR delivery.•Breath-hold gating resulted in a mean tracked GTVt coverage of 99.6% during…”
Get full text

Variations in Target Volume Definition for Postoperative Radiotherapy in Stage III Non–Small-Cell Lung Cancer: Analysis of an International Contouring Study by Spoelstra, Femke O.B., M.D, Senan, Suresh, M.R.C.P., F.R.C.R., Ph.D, Le Péchoux, Cecile, M.D, Ishikura, Satoshi, M.D., Ph.D, Casas, Francesc, M.D, Ball, David, M.B., B.S., M.D., F.R.A.N.Z.C.R, Price, Allan, F.R.C.P., F.R.C.R., Ph.D, De Ruysscher, Dirk, M.D., Ph.D, van Sörnsen de Koste, John R., Ph.D

“…Purpose Postoperative radiotherapy (PORT) in patients with completely resected non–small-cell lung cancer with mediastinal involvement is controversial because…”
Get full text

Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer by Remmerts de Vries, Isabel F., Ronden, Merle I., Bahce, Idris, Spoelstra, Femke O. B., De Haan, Patricia F., Haasbeek, Cornelis J. A., Lissenberg-Witte, Birgit I., Slotman, Ben J., Dahele, Max, Verbakel, Wilko F. A. R.

“…Concurrent chemoradiotherapy (cCRT) is the preferred treatment for stage III NSCLC because surgery containing multimodality treatment is often not appropriate…”
Get full text

Diagnostic challenges in survivors of early stage lung cancer by van Iersel-Vet, Marleen T.A, Thunnissen, Erik, Spoelstra, Femke O.B, Ylstra, Bauke, Slotman, Ben J, Senan, Suresh

“…Highlights • Survivors of early-stage lung cancer are at high risk of developing new lung tumors. • Metastatic disease should be distinguished from second…”
Get full text

Feasibility of using anatomical surrogates for predicting the position of lung tumours by Spoelstra, Femke O.B, van der Weide, Lineke, van Sörnsen de Koste, John R, Vincent, Andrew, Slotman, Ben J, Senan, Suresh

“…Abstract We studied the use of internal anatomical surrogates (carina and diaphragm) for the purpose of predicting the 3D position of lung tumours in 41…”
Get full text

An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting by Elhalawani, Hesham, Elgohari, Baher, Lin, Timothy A., Mohamed, Abdallah S.R., Fitzgerald, Thomas J., Laurie, Fran, Ulin, Kenneth, Kalpathy-Cramer, Jayashree, Guerrero, Thomas, Holliday, Emma B., Russo, Gregory, Patel, Abhilasha, Jones, William, Walker, Gary V., Awan, Musaddiq, Choi, Mehee, Dagan, Roi, Mahmoud, Omar, Shapiro, Anna, Kong, Feng-Ming (Spring), Gomez, Daniel, Zeng, Jing, Decker, Roy, Spoelstra, Femke O.B., Gaspar, Laurie E., Kachnic, Lisa A., Thomas, Charles R., Okunieff, Paul, Fuller, Clifton D.

“…[Display omitted] •We aimed at quantifying inter-observer Pancoast tumors delineation variability.•Experts’ delineations were used to define ground…”
Get full text

Impact of Audio-Coaching on the Position of Lung Tumors by Haasbeek, Cornelis J.A., M.D, Spoelstra, Femke O.B., M.D, Lagerwaard, Frank J., M.D., Ph.D, van Sörnsen de Koste, John R., Ph.D, Cuijpers, Johan P., Ph.D, Slotman, Ben J., M.D., Ph.D, Senan, Suresh, M.R.C.P., F.R.C.R., Ph.D

“…Purpose Respiration-induced organ motion is a major source of positional, or geometric, uncertainty in thoracic radiotherapy. Interventions to mitigate the…”
Get full text

Analysis of reproducibility of respiration-triggered gated radiotherapy for lung tumors by Spoelstra, Femke O.B, van Sörnsen de Koste, John R, Cuijpers, Johan P, Lagerwaard, Frank J, Slotman, Ben J, Senan, Suresh

“…Abstract Purpose Respiration-gated radiotherapy (RGRT) can decrease the toxicity of chemo-radiotherapy (CT-RT) by allowing use of smaller treatment fields…”
Get full text

An Evaluation of Two Internal Surrogates for Determining the Three-Dimensional Position of Peripheral Lung Tumors by Spoelstra, Femke O.B., M.D, van Sörnsen de Koste, John R., Ph.D, Vincent, Andrew, Ph.D, Cuijpers, Johan P., Ph.D, Slotman, Ben J., M.D., Ph.D, Senan, Suresh, M.R.C.P., F.R.C.R., Ph.D

“…Purpose Both carina and diaphragm positions have been used as surrogates during respiratory-gated radiotherapy. We studied the correlation of both surrogates…”
Get full text

Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer by Phernambucq, Erik C.J., Spoelstra, Femke O.B., Paul, Marinus A., Senan, Suresh, Melissant, Christian F., Postmus, Pieter E., Smit, Egbert F.

“…Objective: Concurrent chemoradiotherapy is standard of care in stage III non-small-cell lung cancer, although surgery may be beneficial in selected patients in…”
Get full text

Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors by Finazzi, Tobias, Haasbeek, Cornelis J.A., Spoelstra, Femke O.B., Palacios, Miguel A., Admiraal, Marjan A., Bruynzeel, Anna M.E., Slotman, Berend J., Lagerwaard, Frank J., Senan, Suresh

“…Magnetic resonance (MR)-guided SABR was performed for patients with lung tumors in whom treatment delivery was challenging owing to tumor location, motion, or…”
Get full text

The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis by Ronden, Merle I., Bahce, Idris, Claessens, Niels J.M., Barlo, Nicole, Dahele, Max R., Daniels, Johannes M.A., Tissing-Tan, Caroline, Hekma, Edo, Hashemi, Sayed M.S., van der Wel, Antoinet, Spoelstra, Femke O.B., Verbakel, Wilko F.A. R., Tiemessen, Marian A., van Laren, Marjolein, Becker, Annemarie, Tarasevych, Svitlana, Haasbeek, Cornelis J.A., Maassen van den Brink, Karen, Dickhoff, Chris, Senan, Suresh

“…Treatment patterns in stage III NSCLC can vary considerably between countries. The PACIFIC trial reported improvements in progression-free and overall survival…”
Get full text